Portal Vein Thrombosis

Research output: Contribution to journalReview article

96 Citations (Scopus)

Abstract

Portal vein thrombosis is a condition not infrequently encountered by clinicians. It results from a combination of local and systemic prothrombotic risk factors. The presentation of acute thrombosis varies widely from an asymptomatic state to presence of life-threatening intestinal ischemia and infarction. In the chronic stage, patients typically present with variceal bleeding or other complications of portal hypertension. Abdominal ultrasound color Doppler imaging has a 98% negative predictive value, and is considered the imaging modality of choice in diagnosing portal vein thrombosis. Controlled clinical trials to assist with clinical decision-making are lacking in both acute and chronic portal vein thrombosis. Oral anticoagulant therapy is initiated if the risks of bleeding are low, but long-term anticoagulation is generally not recommended in patients with concomitant hepatic cirrhosis. The roles of invasive therapeutic approaches such as thrombolysis and transjugular intrahepatic portosystemic shunt continue to evolve. This review conflates dissenting views into a rational approach of managing patients with portal vein thrombosis for the general internist.

Original languageEnglish (US)
Pages (from-to)111-119
Number of pages9
JournalAmerican Journal of Medicine
Volume123
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Portal Vein
Thrombosis
Hemorrhage
Transjugular Intrahepatic Portasystemic Shunt
Asymptomatic Diseases
Doppler Ultrasonography
Controlled Clinical Trials
Portal Hypertension
Liver Cirrhosis
Anticoagulants
Infarction
Ischemia
Color
Therapeutics

Keywords

  • Anticoagulation
  • Cirrhosis
  • Coagulopathy
  • Myeloproliferative diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Portal Vein Thrombosis. / Parikh, Sameer A; Shah, Riddhi; Kapoor, Prashant.

In: American Journal of Medicine, Vol. 123, No. 2, 02.2010, p. 111-119.

Research output: Contribution to journalReview article

Parikh, Sameer A ; Shah, Riddhi ; Kapoor, Prashant. / Portal Vein Thrombosis. In: American Journal of Medicine. 2010 ; Vol. 123, No. 2. pp. 111-119.
@article{1c0defcf7d2e47749d4b2fc07e1af92d,
title = "Portal Vein Thrombosis",
abstract = "Portal vein thrombosis is a condition not infrequently encountered by clinicians. It results from a combination of local and systemic prothrombotic risk factors. The presentation of acute thrombosis varies widely from an asymptomatic state to presence of life-threatening intestinal ischemia and infarction. In the chronic stage, patients typically present with variceal bleeding or other complications of portal hypertension. Abdominal ultrasound color Doppler imaging has a 98{\%} negative predictive value, and is considered the imaging modality of choice in diagnosing portal vein thrombosis. Controlled clinical trials to assist with clinical decision-making are lacking in both acute and chronic portal vein thrombosis. Oral anticoagulant therapy is initiated if the risks of bleeding are low, but long-term anticoagulation is generally not recommended in patients with concomitant hepatic cirrhosis. The roles of invasive therapeutic approaches such as thrombolysis and transjugular intrahepatic portosystemic shunt continue to evolve. This review conflates dissenting views into a rational approach of managing patients with portal vein thrombosis for the general internist.",
keywords = "Anticoagulation, Cirrhosis, Coagulopathy, Myeloproliferative diseases",
author = "Parikh, {Sameer A} and Riddhi Shah and Prashant Kapoor",
year = "2010",
month = "2",
doi = "10.1016/j.amjmed.2009.05.023",
language = "English (US)",
volume = "123",
pages = "111--119",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Portal Vein Thrombosis

AU - Parikh, Sameer A

AU - Shah, Riddhi

AU - Kapoor, Prashant

PY - 2010/2

Y1 - 2010/2

N2 - Portal vein thrombosis is a condition not infrequently encountered by clinicians. It results from a combination of local and systemic prothrombotic risk factors. The presentation of acute thrombosis varies widely from an asymptomatic state to presence of life-threatening intestinal ischemia and infarction. In the chronic stage, patients typically present with variceal bleeding or other complications of portal hypertension. Abdominal ultrasound color Doppler imaging has a 98% negative predictive value, and is considered the imaging modality of choice in diagnosing portal vein thrombosis. Controlled clinical trials to assist with clinical decision-making are lacking in both acute and chronic portal vein thrombosis. Oral anticoagulant therapy is initiated if the risks of bleeding are low, but long-term anticoagulation is generally not recommended in patients with concomitant hepatic cirrhosis. The roles of invasive therapeutic approaches such as thrombolysis and transjugular intrahepatic portosystemic shunt continue to evolve. This review conflates dissenting views into a rational approach of managing patients with portal vein thrombosis for the general internist.

AB - Portal vein thrombosis is a condition not infrequently encountered by clinicians. It results from a combination of local and systemic prothrombotic risk factors. The presentation of acute thrombosis varies widely from an asymptomatic state to presence of life-threatening intestinal ischemia and infarction. In the chronic stage, patients typically present with variceal bleeding or other complications of portal hypertension. Abdominal ultrasound color Doppler imaging has a 98% negative predictive value, and is considered the imaging modality of choice in diagnosing portal vein thrombosis. Controlled clinical trials to assist with clinical decision-making are lacking in both acute and chronic portal vein thrombosis. Oral anticoagulant therapy is initiated if the risks of bleeding are low, but long-term anticoagulation is generally not recommended in patients with concomitant hepatic cirrhosis. The roles of invasive therapeutic approaches such as thrombolysis and transjugular intrahepatic portosystemic shunt continue to evolve. This review conflates dissenting views into a rational approach of managing patients with portal vein thrombosis for the general internist.

KW - Anticoagulation

KW - Cirrhosis

KW - Coagulopathy

KW - Myeloproliferative diseases

UR - http://www.scopus.com/inward/record.url?scp=74549150126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74549150126&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2009.05.023

DO - 10.1016/j.amjmed.2009.05.023

M3 - Review article

C2 - 20103016

AN - SCOPUS:74549150126

VL - 123

SP - 111

EP - 119

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 2

ER -